Skip to content

5 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Aug 2026

PD01.08. Optimizing Postoperative Systemic Therapy Following Neoadjuvant Chemoimmunotherapy and Resection for Locally Advanced Esophageal Cancer: A Multicenter Real-World Analysis

Esophageal Cancer: Adjuvant and Neo-Adjuvant Therapies Neoadjuvant chemoimmunotherapy (nICT) followed by surgical resection has emerged as a standard approach for locally advanced esophageal cancer. However, the role and optimal modality of postoperative immunotherapy in patients who have already received...

Yi-Zhou Huang, Mao-Hui Chen, Zhen-Yuan Yang et al. · 0 citations
Aug 2026

P1.137. Baseline Skeletal Muscle Depletion Stratifies Treatment Feasibility and Survival in Locally Advanced Esophageal Squamous Cell Carcinoma Receiving Neoadjuvant Immunochemotherapy

Esophageal Cancer: Other Physiological reserve plays a pivotal role in determining the capacity of patients to tolerate intensive multimodal therapy. In locally advanced esophageal squamous cell carcinoma (ESCC), neoadjuvant immunochemotherapy (nICT) has become increasingly adopted; however, the prognostic...

Yi-Zhou Huang, Mao-Hui Chen, Zhen-Yuan Yang et al. · 0 citations
Aug 2026

PD09.02. Nutritional Vulnerability Predicts Treatment Delivery and Survival in Locally Advanced Esophageal Squamous Cell Carcinoma Undergoing Neoadjuvant Immunochemotherapy

Esophageal Cancer: Other Malnutrition is highly prevalent in esophageal squamous cell carcinoma (ESCC) and may critically modulate host resilience to intensive multimodal therapy. In the era of neoadjuvant immunochemotherapy (nICT), the prognostic utility of structured nutritional assessment remains incomp...

Mao-Hui Chen, Yi-Zhou Huang, T. Zeng et al. · 0 citations
Aug 2026

P1.138. Preoperative Systemic Inflammatory Burden as a Determinant of Long-Term Outcomes After Neoadjuvant Chemotherapy in Esophageal Squamous Cell Carcinoma

Elevated preoperative systemic inflammatory burden represents a readily accessible and clinically informative biomarker in ESCC patients undergoing NCT that enhances risk stratification and may inform individualized postoperative management strategies.

T. Zeng, Yi-Zhou Huang, Zhen-Yuan Yang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.